Ocular complications of topical, peri-ocular, and systemic corticosteroids.
about
Prophylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgerySpecific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cellsAlopecia areata: Part 2: treatmentCorticosteroid treatment of periorbital haemangioma of infancy: a review of the evidence.Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.British Association of Dermatologists' guidelines for the management of alopecia areata 2012.Emerging treatment options for meibomian gland dysfunction.Treatment of Sarcoidosis.Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effectsLong-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.Corneal lymphangiogenesis in herpetic stromal keratitisOcular hypertension after pediatric cataract surgery: baseline characteristics and first-year report.Assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas.The influence of anti-VEGF therapy on present day management of macular edema due to BRVO and CRVO: a longitudinal analysis on visual function, injection time interval and complications.Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome.Glucocorticoids in the treatment of early and late RAOcular side-effects of topical corticosteroids: what a dermatologist needs to know.Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups.Long-term Fluorometholone Topical Use Induces Ganglion Cell Damage in Rats Analyzed With Optical Coherence Tomography.Ocular manifestations of inflammatory bowel disease.Efficacy of topical blockade of interleukin-1 in experimental dry eye diseaseTreating Alopecia Areata: Current Practices Versus New Directions.The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitisOutcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.Ocular manifestations of systemic lupus erythematosus: a clinical review.Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis.Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic managementOvarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.RETRACTED: Piceatannol suppresses endotoxin-induced ocular inflammation in rats.Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats.Severe Corticosteroid-Induced Ocular Hypertension Requiring Bilateral Trabeculectomies in a Patient with Takayasu's Arteritis.Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetesSteroid-induced iatrogenic glaucoma.Management of seasonal allergic conjunctivitis: guide to therapy.Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
P2860
Q24234054-F10DD47F-6369-4820-BF37-7D448A00E335Q24655239-958A1862-5332-4233-89FD-F867D339730BQ28080455-09B6EBA6-1919-49FD-AC5B-EFB9D0EF7492Q30859813-22EE6070-404C-400F-B7CF-840DAC918207Q34080132-804B1F6E-5244-42F8-8E33-82ECFC42A306Q34242074-B0EAC7F1-6917-47BD-B2B0-01D9466791D8Q34371781-1FC3E9DE-918D-4CA8-873E-EDACCB346DE8Q34477003-5B7A1A94-CE73-43BE-8035-5C94B9DB77E0Q34543852-0D2B71BA-3463-42CC-AC8D-239E38750BFAQ34597321-45697F43-3F1B-4479-9B2D-78716C2FE928Q34659232-44B5E740-379B-47D9-BBC2-6EC1173508C3Q34674612-17B7D71F-BF7A-450F-A8F5-620A9B2D8467Q34904457-AC2A0B90-C77F-4D65-AFA8-87BD40B4289BQ35196233-4D27721C-1E20-4AF1-B6C3-EC28CCB05FAFQ35269542-8AA4DA7C-EA0A-4559-A071-EB7E5D8ADC0EQ35529254-95B99577-3930-46B5-8F08-CEBE10E88B4DQ35552156-B6B32390-C93C-4108-B749-3F43C582F251Q35574205-5E0B9EA6-A556-4C57-BA00-7167995D42C5Q35605617-D99E54FC-0AE8-410A-94A9-F9BFE28D97FDQ35682485-3F33A839-746A-4887-9EAF-0E184A28D56EQ35787601-CF7F4B8F-1458-42E3-BE32-8AFF739C07D6Q36044544-68A99993-C161-459C-AA5E-DD58AE5692BDQ36171921-BF9B7BE9-37C0-4D62-9EF5-58C0A6B1B43EQ36193029-4735CF82-667E-43A6-9030-EA1320F2D491Q36193630-03C34732-C3CD-432A-9421-9247D25C07A5Q36228580-B1FF5618-2BAB-43F2-BFDB-4FB02C91ACB1Q36398299-03FE37C7-EB47-4B7F-BF1F-2A2D389B2BB4Q36407719-DF692942-605E-4C89-86F3-85C4EBAD5B0AQ36443965-260A90EA-A46B-4DD0-A7D2-92FCD847D127Q36533886-6C0E7F7A-C1A0-4AEB-A0F9-731A486ABAF1Q36920430-D0872188-41A3-4F59-91E0-54C8729498E9Q37105605-B04FFEAC-E7C3-4EE0-96B2-8334161C509AQ37205710-64AE998D-1ECA-4F54-8410-34BEE92081D2Q37317951-82E61E98-3F69-4A8A-AC48-B4F27109279BQ37434479-5BA2A0F2-0AD7-4AE2-9861-AF8EC1EE31CFQ37703235-5F8FD9E5-1A4E-4426-9004-8A2ECF9A951FQ37901293-6E6CAF3C-C4A2-42CD-98E6-EE5AD9D2FE9DQ37954005-B7DE263D-598C-4F09-A58A-D034B9901A58Q38102592-7610B87D-D6E9-4F4B-9999-BC3F80BCF1F0Q38179488-FB991461-E79F-46F0-B69B-A388FC14CD55
P2860
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@ast
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@en
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@nl
type
label
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@ast
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@en
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@nl
prefLabel
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@ast
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@en
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@nl
P1476
Ocular complications of topical, peri-ocular, and systemic corticosteroids.
@en
P2093
Carnahan MC
Goldstein DA
P304
P356
10.1097/00055735-200012000-00016
P577
2000-12-01T00:00:00Z